Climb Bio, Inc.

NASDAQ:CLYM

Biotechnology

Healthcare
$9.78 +0.17%

+$0.02 today

Market cap
$574.46M
Beta
0.10
P/E (TTM)
-14.7
EPS (TTM)
-$0.77
52W Low $1.17High $12.48

Volume 0.59M

Average 0.88M

Private 5-step workspace

Build a CLYM investment thesis

Turn Climb Bio, Inc. research into a structured decision across business quality, moat, management, intrinsic value, and synthesis.

Log in to save your stock analysis
Your answers are private and saved per stock, so you can come back to the thesis later.